| Key Financial Ratios of Bliss GVS Pharma (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
6.56 |
4.85 |
8.23 |
8.97 |
6.54 |
|
| Diluted EPS (Rs.) |
6.50 |
4.77 |
8.10 |
8.81 |
6.40 |
|
| Cash EPS (Rs.) |
9.11 |
7.08 |
9.66 |
10.27 |
7.88 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
100.47 |
94.42 |
89.96 |
82.12 |
73.26 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
100.47 |
94.42 |
89.96 |
82.12 |
73.26 |
|
| Dividend / Share(Rs.) |
0.50 |
0.50 |
0.50 |
0.50 |
0.50 |
|
| Revenue from Operations/Share (Rs.) |
63.32 |
57.83 |
57.45 |
61.38 |
45.13 |
|
| PBDIT/Share (Rs.) |
12.13 |
13.44 |
13.53 |
13.68 |
10.58 |
|
| PBIT/Share (Rs.) |
9.56 |
11.19 |
12.07 |
12.34 |
9.25 |
|
| PBT/Share (Rs.) |
8.94 |
6.71 |
11.11 |
12.19 |
8.84 |
|
| Net Profit/Share (Rs.) |
6.55 |
4.84 |
8.21 |
8.94 |
6.54 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
19.15 |
23.23 |
23.55 |
22.28 |
23.44 |
|
| PBIT Margin (%) |
15.10 |
19.34 |
21.01 |
20.11 |
20.48 |
|
| PBT Margin (%) |
14.11 |
11.60 |
19.33 |
19.86 |
19.58 |
|
| Net Profit Margin (%) |
10.33 |
8.36 |
14.28 |
14.56 |
14.50 |
|
| Return on Networth / Equity (%) |
6.51 |
5.12 |
9.12 |
10.88 |
8.93 |
|
| Return on Capital Employed (%) |
9.20 |
11.31 |
12.74 |
14.42 |
11.92 |
|
| Return on Assets (%) |
5.65 |
4.39 |
7.50 |
8.58 |
7.13 |
|
| Total Debt/Equity (X) |
0.05 |
0.07 |
0.08 |
0.10 |
0.09 |
|
| Asset Turnover Ratio (%) |
0.56 |
0.53 |
0.54 |
0.63 |
49.22 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
6.16 |
6.59 |
4.76 |
4.10 |
4.63 |
|
| Quick Ratio (X) |
5.51 |
5.83 |
4.27 |
3.63 |
4.06 |
|
| Inventory Turnover Ratio (X) |
7.72 |
3.74 |
3.58 |
4.04 |
5.56 |
|
| Dividend Payout Ratio (NP) (%) |
7.60 |
10.28 |
6.07 |
5.58 |
7.64 |
|
| Dividend Payout Ratio (CP) (%) |
5.46 |
7.02 |
5.15 |
4.85 |
6.34 |
|
| Earnings Retention Ratio (%) |
92.40 |
89.72 |
93.93 |
94.42 |
92.36 |
|
| Cash Earnings Retention Ratio (%) |
94.54 |
92.98 |
94.85 |
95.15 |
93.66 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
1,118.52 |
1,075.66 |
734.56 |
733.93 |
966.41 |
|
| EV/Net Operating Revenue (X) |
1.68 |
1.78 |
1.23 |
1.15 |
2.08 |
|
| EV/EBITDA (X) |
8.75 |
7.65 |
5.21 |
5.17 |
8.85 |
|
| MarketCap/Net Operating Revenue (X) |
1.86 |
1.95 |
1.24 |
1.25 |
2.19 |
|
| Retention Ratios (%) |
92.39 |
89.71 |
93.92 |
94.41 |
92.35 |
|
| Price/BV (X) |
1.17 |
1.19 |
0.79 |
0.94 |
1.35 |
|
| Price/Net Operating Revenue |
1.86 |
1.95 |
1.24 |
1.25 |
2.19 |
|
| Earnings Yield |
0.06 |
0.04 |
0.12 |
0.12 |
0.07 |
|
Source : Dion Global Solutions Limited
